PRODUCT DETAILS

About Klat 250 mg/250 mg Tablet

ETAMSYLATE+TRANEXAMIC ACID belongs to the class of medications called ‘Antihemorrhagic agents’ used to treat menorrhagia. Menorrhagia is a condition characterized by heavy or prolonged bleeding during menstrual periods. You are said to have menorrhagia if the bleeding is heavy to disrupt your daily activities, soaking one or more sanitary pads or tampons every hour for several consecutive hours, bleeding for more than a week, and experiencing symptoms such as fatigue, weakness, pale face, and shortness of breath. It is also used to stop postoperative hemorrhage (excessive bleeding after a surgical procedure), and local fibrinolysis (abnormal breakdown of blood clots)

ETAMSYLATE+TRANEXAMIC ACID is a combination of two medicines: Tranexamic acid and Etamsylate. Tranexamic acid belongs to the class of ‘anti-fibrinolytic agents’ which acts by regulating the breakdown of blood clots. It blocks the release and action of plasmin, an enzyme essential for the breakdown of clots present in the blood. Etamsylate is a hemostatic agent (prevents bleeding). It increases the ability of platelets to stick together (platelet adhesion) and form blood clots. It inhibits the action of chemical substances that cause the breakdown of platelets. These effects help to decrease abnormal bleeding.

Uses of Klat 250 mg/250 mg Tablet

Menorrhagia, Postoperative hemorrhage (excessive bleeding after a surgical procedure), and local fibrinolysis (abnormal breakdown of blood clots)

Medicinal Benefits of Klat 250 mg/250 mg Tablet

ETAMSYLATE+TRANEXAMIC ACID is a combination of two medicines: Tranexamic acid and Etamsylate. Tranexamic acid belongs to the class of ‘anti-fibrinolytic agents’. It acts by regulating the breakdown of blood clots in the body. It blocks the release and action of plasmin, an enzyme essential for the breakdown of clots present in the blood. Etamsylate increases the ability of platelets to stick together (platelet adhesion) and form blood clots. It inhibits the action of chemical substances that cause the breakdown of platelets. This effect helps to slow down the abnormal bleeding.

Directions for Use

Swallow ETAMSYLATE+TRANEXAMIC ACID as a whole with a glass of water. Do not break, chew, or crush the tablet/capsule. The dose and duration are prescribed by the doctor based on your condition.

Side Effects of Klat 250 mg/250 mg Tablet

• Nausea (feeling sick)
• Vomiting (being sick)
• Diarrhea
• Stomach pain
• Swelling of face, lips, eyelids, tongue, hands, and feet
• Dizziness
• Headache
• Chills
• Fever
• Rash
• Pale skin
• Severe headache
• Back or joint pain
• Muscle pain
• Difficulty moving
• Difficulty breathing
• Runny or stuffy nose

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug-Disease Interaction:

ETAMSYLATE+TRANEXAMIC ACID may interact with birth control pills, fibrinolytic drugs (streptokinase, urokinase, reteplase, and alteplase, etc.), an antipsychotic drug (chlorpromazine), and a drug used to treat blood cancer (tretinoin), and progestins (levonorgestrel).

Safety Advice

ALCOHOL

Consumption of alcohol may worsen your health condition as it may increase the risk of side-effects.

PREGNANCY

ETAMSYLATE+TRANEXAMIC ACID is a category B medicine and may not show any toxic effects to the fetus.

BREAST FEEDING

ETAMSYLATE+TRANEXAMIC ACID may get secreted in breast milk in very low amounts.

DRIVING

ETAMSYLATE+TRANEXAMIC ACID may not affect your ability to drive.

LIVER

ETAMSYLATE+TRANEXAMIC ACID is probably safe in patients with liver diseases.

KIDNEY

ETAMSYLATE+TRANEXAMIC ACID is probably safe in patients with kidney diseases.